Literature DB >> 25875428

Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.

Imane Allali1, Susana Delgado, Pablo Isidro Marron, Aurora Astudillo, Jen Jen Yeh, Hassan Ghazal, Saaïd Amzazi, Temitope Keku, M Andrea Azcarate-Peril.   

Abstract

Colorectal cancer (CRC) is the third most common cancer in the world and the second leading cause of cancer deaths in the US and Spain. The molecular mechanisms involved in the etiology of CRC are not yet elucidated due in part to the complexity of the human gut microbiota. In this study, we compared the microbiome composition of 90 tumor and matching adjacent tissue (adjacent) from cohorts from the US and Spain by 16S rRNA amplicon sequencing in order to determine the impact of the geographic origin on the CRC microbiome. Data showed a significantly (P < 0.05) higher Phylogenetic Diversity (PD) for the US (PD Adjacent = 26.3 ± 5.3, PD Tumor = 23.3 ± 6.2) compared to the Spanish cohort (PD Adjacent = 18.9 ± 5.9, PD Tumor = 18.7 ± 6.6) while no significant differences in bacterial diversity were observed between tumor and adjacent tissues for individuals from the same country. Adjacent tissues from the Spanish cohort were enriched in Firmicutes (SP = 43.9% and US = 22.2%, P = 0.0001) and Actinobacteria (SP = 1.6% and US = 0.5%, P = 0.0018) compared to US adjacent tissues, while adjacent tissues from the US had significantly higher abundances of Fusobacteria (US = 8.1% and SP = 1.5%, P = 0.0023) and Sinergistetes (US = 0.3% and SP = 0.1%, P = 0.0097). Comparisons between tumor and adjacent tissues in each cohort identified the genus Eikenella significantly over represented in US tumors (T = 0.024% and A = 0%, P = 0.03), and the genera Fusobacterium (T = 10.4% and A = 1.5%, P = <0.0001), Bulleida (T = 0.36% and A = 0.09%, P = 0.02), Gemella (T = 1.46% and A = 0.19%, P = 0.03), Parvimonas (T = 3.14% and A = 0.86%, P = 0.03), Campylobacter (T = 0.15% and A = 0.008%, P = 0.047), and Streptococcus (T = 2.84% and A = 2.19%, P = 0.05) significantly over represented in Spanish tumors. Predicted metagenome functional content from 16S rRNA surveys showed that bacterial motility proteins and proteins involved in flagellar assembly were over represented in adjacent tissues of both cohorts, while pathways involved in fatty acid biosynthesis, the MAPK signaling pathway, and bacterial toxins were over represented in tumors. Our study suggests that microbiome compositional and functional dissimilarities by geographic location should be taken in consideration when approaching CRC therapeutic options.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25875428      PMCID: PMC4615176          DOI: 10.1080/19490976.2015.1039223

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  76 in total

1.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis.

Authors:  T Ohkusa; I Okayasu; T Ogihara; K Morita; M Ogawa; N Sato
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?

Authors:  M Andrea Azcárate-Peril; Michael Sikes; José M Bruno-Bárcena
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

Review 3.  Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.

Authors:  Muhammad I Naseer; Fehmida Bibi; Mohammed H Alqahtani; Adeel G Chaudhary; Esam I Azhar; Mohammad A Kamal; Muhammad Yasir
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

4.  Enterotypes of the human gut microbiome.

Authors:  Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork
Journal:  Nature       Date:  2011-04-20       Impact factor: 49.962

5.  Microbiota organization is a distinct feature of proximal colorectal cancers.

Authors:  Christine M Dejea; Elizabeth C Wick; Elizabeth M Hechenbleikner; James R White; Jessica L Mark Welch; Blair J Rossetti; Scott N Peterson; Erik C Snesrud; Gary G Borisy; Mark Lazarev; Ellen Stein; Jamuna Vadivelu; April C Roslani; Ausuma A Malik; Jane W Wanyiri; Khean L Goh; Iyadorai Thevambiga; Kai Fu; Fengyi Wan; Nicolas Llosa; Franck Housseau; Katharine Romans; XinQun Wu; Florencia M McAllister; Shaoguang Wu; Bert Vogelstein; Kenneth W Kinzler; Drew M Pardoll; Cynthia L Sears
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

Review 6.  The role of the gastrointestinal microbiota in colorectal cancer.

Authors:  Ian R Rowland
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  The human gut microbiome as a screening tool for colorectal cancer.

Authors:  Joseph P Zackular; Mary A M Rogers; Mack T Ruffin; Patrick D Schloss
Journal:  Cancer Prev Res (Phila)       Date:  2014-08-07

Review 8.  The gut microbiota and obesity: from correlation to causality.

Authors:  Liping Zhao
Journal:  Nat Rev Microbiol       Date:  2013-08-05       Impact factor: 60.633

9.  Linking long-term dietary patterns with gut microbial enterotypes.

Authors:  Gary D Wu; Jun Chen; Christian Hoffmann; Kyle Bittinger; Ying-Yu Chen; Sue A Keilbaugh; Meenakshi Bewtra; Dan Knights; William A Walters; Rob Knight; Rohini Sinha; Erin Gilroy; Kernika Gupta; Robert Baldassano; Lisa Nessel; Hongzhe Li; Frederic D Bushman; James D Lewis
Journal:  Science       Date:  2011-09-01       Impact factor: 47.728

10.  Towards the human colorectal cancer microbiome.

Authors:  Julian R Marchesi; Bas E Dutilh; Neil Hall; Wilbert H M Peters; Rian Roelofs; Annemarie Boleij; Harold Tjalsma
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

View more
  41 in total

1.  Comparative and analytical characterization of the oral bacteriome of smokeless tobacco users with oral squamous cell carcinoma.

Authors:  Ankita Srivastava; SukhDev Mishra; Pankaj Kumar Garg; Ashok Kumar Dubey; S V S Deo; Digvijay Verma
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-21       Impact factor: 4.813

2.  Super-taxon in human microbiome are identified to be associated with colorectal cancer.

Authors:  Wei Dai; Cai Li; Ting Li; Jianchang Hu; Heping Zhang
Journal:  BMC Bioinformatics       Date:  2022-06-21       Impact factor: 3.307

Review 3.  Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-18       Impact factor: 11.382

Review 4.  Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology.

Authors:  Mukesh Verma
Journal:  Technol Cancer Res Treat       Date:  2016-06-22

Review 5.  Emerging Technologies for Gut Microbiome Research.

Authors:  Jason W Arnold; Jeffrey Roach; M Andrea Azcarate-Peril
Journal:  Trends Microbiol       Date:  2016-07-15       Impact factor: 17.079

6.  Diet, Gut Microbiota, and Colorectal Cancer Prevention: A Review of Potential Mechanisms and Promising Targets for Future Research.

Authors:  Mingyang Song; Andrew T Chan
Journal:  Curr Colorectal Cancer Rep       Date:  2017-09-04

7.  The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies.

Authors:  Inge Huybrechts; Semi Zouiouich; Astrid Loobuyck; Zeger Vandenbulcke; Emily Vogtmann; Silvia Pisanu; Isabel Iguacel; Augustin Scalbert; Iciar Indave; Vitaly Smelov; Marc J Gunter; Nathalie Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

Review 8.  Bacterial Toxins Are a Never-Ending Source of Surprises: From Natural Born Killers to Negotiators.

Authors:  Maria Lopez Chiloeches; Anna Bergonzini; Teresa Frisan
Journal:  Toxins (Basel)       Date:  2021-06-17       Impact factor: 4.546

9.  Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer.

Authors:  Shujiro Okuda; Yoshifumi Shimada; Yosuke Tajima; Kizuki Yuza; Yuki Hirose; Hiroshi Ichikawa; Masayuki Nagahashi; Jun Sakata; Yiwei Ling; Nobuaki Miura; Mika Sugai; Yu Watanabe; Shiho Takeuchi; Toshifumi Wakai
Journal:  Comput Struct Biotechnol J       Date:  2021-06-04       Impact factor: 7.271

10.  Optimized bacterial DNA isolation method for microbiome analysis of human tissues.

Authors:  Carlijn E Bruggeling; Daniel R Garza; Soumia Achouiti; Wouter Mes; Bas E Dutilh; Annemarie Boleij
Journal:  Microbiologyopen       Date:  2021-06       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.